CSAM Health Group AS
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CSAMF research report →
Companywww.csamhealth.com
CSAM Health Group AS provides various ehealth solutions in Norway and internationally. The company offers CSAM Arcidis, an integrated system for teleradiology; CSAM DICOM Server for handling radiology data; CSAM HelseMail for transfer of confidential patient data between healthcare organizations; CSAM Infobroker, a vendor-neutral telemedicine system for radiology that enables multiple clinicians to share resources and knowledge; CSAM S7, a platform for self-care and health counselling; CSAM Web Client, a web-based user interface and connectivity solution that allows users to access multiple CSAM applications and functions; and CSAM XDS, a central archive for storing and managing various types of clinical patient data. It also provides CSAM Cardio, an ECG and diagnostic storage tool; CSAM CIMA, a mobile application for capturing, using, and sending medical media; CSAM Media, a web-based medical imaging solution; CSAM Medimaker for image management and workflow solution; CSAM Picsara, an image management solution; and CSAM TRIS, a radiology information system.
- CEO
- Sverre Flatby
- IPO
- 2022
- Employees
- 268
- HQ
- Oslo, NO
Price Chart
Valuation
- Market Cap
- $98.80M
- P/E
- 119.46
- P/S
- 1.60
- P/B
- 29.60
- EV/EBITDA
- 9.18
- Div Yield
- 1.22%
Profitability
- Gross Margin
- 74.46%
- Op Margin
- 10.06%
- Net Margin
- 1.34%
- ROE
- 21.66%
- ROIC
- 3.16%
Growth & Income
- Revenue
- $424.96M · 3.53%
- Net Income
- $-59,290,000 · -156.82%
- EPS
- $-2.94 · -157.53%
- Op Income
- $-3,137,000
- FCF YoY
- 1285.73%
Performance & Tape
- 52W High
- $4.82
- 52W Low
- $4.82
- 50D MA
- $4.82
- 200D MA
- $4.82
- Beta
- 0.58
- Avg Volume
- 0
Get TickerSpark's AI analysis on CSAMF
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our CSAMF Coverage
We haven't published any research on CSAMF yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate CSAMF Report →